Diasorin SpA (LTS:0GZX) Construction In Progress : €0 Mil (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Construction In Progress?

Diasorin SpA's quarterly construction in progress increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€34 Mil) but then declined from Dec. 2024 (€34 Mil) to Mar. 2025 (€0 Mil).

Diasorin SpA's annual construction in progress declined from Dec. 2022 (€34 Mil) to Dec. 2023 (€30 Mil) but then increased from Dec. 2023 (€30 Mil) to Dec. 2024 (€34 Mil).

Diasorin SpA Construction In Progress Historical Data

The historical data trend for Diasorin SpA's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Construction In Progress Chart

Diasorin SpA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

15.66

27.61

34.38

30.17

33.94

Diasorin SpA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															-	35.72	-	33.94	-

Diasorin SpA Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Diasorin SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (LTS:0GZX) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

DSRLF:USA DIA:Italy DIAm:UK 34D:Germany DIAS:Austria

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines